Prestige Consumer Healthcare (PBH) Non-Current Deferred Tax Liability (2011 - 2026)

Prestige Consumer Healthcare's Non-Current Deferred Tax Liability history runs 15 years deep, the most recent figure standing at $449.3 million for Q4 2025.

• In Q4 2025, Non-Current Deferred Tax Liability rose 8.72% year-over-year to $449.3 million; the TTM figure through Dec 2025 stood at $449.3 million (up 8.72% YoY), while the FY2025 annual figure was $419.6 million, up 3.96% from the prior year.
• Non-Current Deferred Tax Liability for Q4 2025 stood at $449.3 million, up from $444.9 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $455.8 million in Q4 2022, with the low at $384.0 million in Q2 2023.
• The 5-year median for Non-Current Deferred Tax Liability is $430.5 million (2021), against an average of $425.9 million.
• The sharpest annual moves came in 2023 and 2025: Non-Current Deferred Tax Liability retreated 13.24% in 2023, then climbed 8.72% in 2025.
• Prestige Consumer Healthcare's Non-Current Deferred Tax Liability stood at $444.8 million in 2021, then advanced by 2.48% to $455.8 million in 2022, then decreased by 12.87% to $397.1 million in 2023, then increased by 4.06% to $413.3 million in 2024, then rose by 8.72% to $449.3 million in 2025.
• Business Quant data shows PBH's Non-Current Deferred Tax Liability at $449.3 million in Q4 2025, $444.9 million in Q3 2025, and $426.9 million in Q2 2025.